Evidence map›Paper›PMID 39849058›Full record

ArticleScientific reports2025

A de novo, mosaic and complex chromosome 21 rearrangement causes APP triplication and familial autosomal dominant early onset Alzheimer disease.

Emma Ehn, Jesper Eisfeldt, Jose M Laffita-Mesa, Håkan Thonberg, Jacqueline Schoumans, Anne M Portaankorva, Matti Viitanen, Anna Lindstrand, Inger Nennesmo, Caroline Graff

Erratum issuedAbstract readCase Reports
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Emma EhnDivision for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. emma.ehn@ki.se.
Jesper EisfeldtDepartment for Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Jose M Laffita-MesaDivision for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Håkan ThonbergDepartment for Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Jacqueline SchoumansDépartement de Médicine de Laboratoire et Pathologie, Centre Universitaire Hospitalier Vaudois (CHUV), Lausanne, Switzerland.
Anne M PortaankorvaFaculty of Medicine, Clinical Neurosciences, University of Helsinki, Helsinki, Finland.
Matti ViitanenDivision for Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Anna LindstrandDepartment for Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Inger NennesmoDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Caroline GraffDivision for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copy number variation (CNV) of the amyloid-β precursor protein gene (APP) is a known cause of autosomal dominant Alzheimer disease (ADAD), but de novo genetic variants causing ADAD are rare. We report a mother and daughter with neuropathologically confirmed definite Alzheimer disease (AD) and extensive cerebral amyloid angiopathy (CAA). Copy number analysis identified an increased number of APP copies and genome sequencing (GS) revealed the underlying complex genomic rearrangement (CGR) including a triplication of APP with two unique breakpoint junctions (BPJs). The mosaic state in the mother had likely occurred de novo. Digital droplet PCR (ddPCR) on 42 different tissues, including 17 different brain regions, showed the derivative chromosome at varying mosaic levels (20-96%) in the mother who had symptom onset at age 58 years. In contrast, the derivative chromosome was present in all analyzed cells in the daughter whose symptom onset was at 34 years. This study reveals the architecture of a de novo CGR causing APP triplication and ADAD with a striking difference in age at onset between the fully heterozygous daughter compared to the mosaic mother. The GS analysis identified the complexity of the CGR illustrating its usefulness in identifying structural variants (SVs) in neurodegenerative disorders.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorDNA Copy Number VariationsMosaicismAdultAge of OnsetChromosomes, Human, Pair 21FemaleHumansMiddle AgedPedigreeAmyloid beta-Protein PrecursorAPP protein, humanAmyloid-β precursor protein gene (APP)Autosomal dominant Alzheimer disease (ADAD)Cerebral amyloid angiopathy (CAA)Complex genomic rearrangement (CGR)MosaicismStructural variant (SV).

Identifiers

PMID39849058
PMCPMC11759332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.